Búsqueda de un proyecto
Otra(s) opcion(es) de búsqueda
33 Resultado(s)
Proyectos de investigación terminados = 
Financiado por un miembro del IRDiRC = 
Miembro de una ERN = 
Proyectos de investigación
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Novel mri methods for osteochondritis dissecans (ocd) / osteochondrosis (oc)
Institution: Information not provided - US
ALEMANIA
Hamburg
HAMBURG
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
AKK Altonaer Kinderkrankenhaus gGmbH
Fachabteilung für Kinderorthopädie
ALEMANIA
Schleswig-Holstein
LÜBECK
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Klinik für Orthopädie und Unfallchirurgie - Sektion für Orthopädie
BELGICA
ANTWERPEN
EDEGEM (ANTWERPEN)
BETCON: A Multicenter Randomized Controlled Open-label Trial of Conservative Management Versus Minimally Invasive Treatment With Leukocyte- and Platelet-rich Fibrin Versus Primary Surgery in Patients With Newly Diagnosed Osteonecrosis of the Jaw - BE
Antwerp University Hospital - UZA
Nucleaire geneeskunde - UZA
ALEMANIA
Mecklenburg-Vorpommern
ROSTOCK
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
Adakveo (crizanlizumab) PRegnancy outcomes Intensive Monitoring (PRIM) - AT
Institution: Information not provided - AT
ESPAÑA
Aragón
ZARAGOZA
Validación de un conjunto de potenciales biomarcadores predictivos de complicaciones óseas en pacientes con enfermedad de Gaucher tipo 1 -ES
Fundación Española para el estudio y terapéutica de la enfermedad de Gaucher
ESPAÑA
Cataluña
BARCELONA
Medicina personalizada en pacientes con enfermedad de células falciformes basada en el diagnóstico integrado de metodologías de nueva generación
Vall d'Hebron Institut de Recerca VHIR
Vall d'Hebron Institut de Recerca
ESTADOS UNIDOS
North Carolina
CHAPEL HILL
Prospective Study in Sickle Cell Anemia: Determine Biomarkers of Endothelial Function Changes in Chronic Kidney Disease
University of North Carolina
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Therapeutics for rare and neglected diseases - science
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Preclinical innovation
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Genetic epidemiology of complex traits
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Insights into sickle cell trait and sickle cell disease
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Red cell biology
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Understanding the relationships between race; ethnicity; ancestry and genomics
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Neuro-ophthalmic mechanisms of disease
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
The impact of childhood chronic disease on child patient reported outcomes
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Mri-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Age-dependence of cerebral oxygen metabolism and stroke risk in pediatric sickle cell disease
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Insights into Sickle Cell Trait and Sickle Cell Disease
Institution: Information not provided - US
FINLANDIA
Finland
HELSINKI
Genomic editing for treating hemoglobin diseases
University of Helsinki
Stem Cells and Metabolism Research Program
FRANCIA
ILE-DE-FRANCE
PARIS
Non-invasive prenatal diagnosis of sickle cell anemia by next generation sequencing (NGS)
CHU Paris - Hôpital Robert Debré
UF de Génétique Moléculaire
FRANCIA
ILE-DE-FRANCE
PARIS
Constitutive hematologic diseases: clinical and therapeutic research, molecular biology
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Service d'hématologie pédiatrique
FRANCIA
ILE-DE-FRANCE
PARIS
CRISPR/Cas9 mediated induction of fetal hemoglobin synthesis for the treatment of beta-hemoglobinopathies
IMAGINE - Institut des Maladies Génétiques
Institut IMAGINE - INSERM U1163
FRANCIA
ILE-DE-FRANCE
PARIS
Development of Innovative Therapeutic Strategies for Beta-Hemoglobinopathies
IMAGINE - Institut des Maladies Génétiques
Institut IMAGINE - INSERM U1163
FRANCIA
ILE-DE-FRANCE
PARIS
Improvement of gene therapy strategies based on the use of hematopoietic stem cells for the treatment of ß-hemoglobinopathies
IMAGINE - Institut des Maladies Génétiques
Institut IMAGINE - INSERM U1163
ITALIA
LAZIO
ROMA
Advances in diagnosis of thalassemia and haemoglobinopathies: development of innovative techniques by thermogravimetry coupled with chemometrics
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci
PORTUGAL
NORTE
PORTO
The sorting and trafficking of lysosomal proteins through M6P independent pathways: molecular, biochemical and functional studies
Instituto Nacional de Saúde Dr. Ricardo Jorge - Porto
Unidade de Investigação & Desenvolvimento; Departamento de Genética
PORTUGAL
SUL
LISBOA
Development and validation of vaso-occlusion early predictors in mendelian model of vascular disease
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Departamento de Genética
ESPAÑA
Murcia
MURCIA
Secuenciación de 4ª generación con nanoporos en el diagnóstico de enfermedades genéticas
Hospital General Universitario Reina Sofía
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Proyectos de investigación multicéntricos
- Universitätsklinikum des Saarlandes
- Institut für Molekulare Zellbiologie
- The Cyprus Institute of Neurology and Genetics
- Department of molecular genetics A
- Groupe hospitalier AP-HP.6 - Hôpital Tenon
- Laboratoire d'Hémostase et de Thrombose
ALEMANIA
Saarland
HOMBURG
CoMMiTMenT: Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments
CHIPRE
Cyprus
NICOSIA
ITHANET: Euromediterranean network of research centres conducting molecular and clinical research of thalassaemia and related haemoglobinopathies
FRANCIA
ILE-DE-FRANCE
PARIS